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autism spectrum disorders; cell adhesion; neurexin; synaptic efficacy THE RECENT ARTICLE from Aoto et al. (2013) has made important additions to the hypothesis that mutations in genes encoding synaptic cell adhesion proteins can generate autistic spectrum disorders (ASD). This hypothesis has its foundations in human genetic screenings that show significant correlation between mutations in the neurexin (NRXN) and neuroligin (NLGN) genes and diagnosed ASD (reviewed in Reichelt et al. 2012) . Along with providing a rationale for this mechanistic hypothesis for ASD pathophysiology, these genetic screens provide a rich source of target mutations conventionally referred to as "ASD susceptibility genes" from which to generate animal models of these diseases.
Autism has shown an astounding increase in prevalence in the past decade, which cannot be attributed to simple increases in diagnosis. In fact, the advances in autism genetics have expanded the disease from the classical autistic phenotype, characterized by social impairments, as well as highly restrictive patterns of behavior and/or interests, into the autism spectrum of disorders, which more closely aligns the diagnosis and hypothesized pathophysiology of other neurological conditions such as Fragile X, Rett Syndrome, and neurofibromitosis with classically characterized autism (reviewed in Südhof 2008) .
One of the primary themes to arise from the growing list of ASD susceptibility genes is that of synaptic dysfunction taking a primary role in ASD pathophysiology. Genes such as PTEN and MET contribute to the mTOR pathway governing activity-dependent synaptic protein synthesis while mutations in UBE3A and USP7 disrupt the function of ubiquitination pathways and synaptic protein metabolism (reviewed in Chen et al. 2014) . Most pertinent to the paper at hand is the growing list of ASD susceptibility genes that contribute to pre-post synaptic cell adhesion. As has been shown by Aoto et al. (2013) and others, mutations to genes encoding neurexins, neuroligins, and numerous other cell adhesion molecules have shown high prevalence in human genetic studies (reviewed in Berg and Geschwind 2012) . Human characterizations of Nrxn3 mutations have been recently characterized by Vaags et al. (2012) . From these target mutations, multiple animal models have been generated using conventional knockout strategies (reviewed in Südhof 2008) .
A more recent refinement to the cell adhesion hypothesis of ASD is that mutations affecting splicing dynamics of the 6 NRXN proteins (␣ and ␤ forms of the 3 genes; reviewed in Tabuchi and Südhof 2002) constitute an equally viable mechanism of ASD pathogenesis compared with conventional Nrxn gene knockout. Alternative splicing of NRXN genes is heavily regulated, creating a complex and highly dynamic system of synaptic protein expression (Resnick et al. 2008) . Presynaptic cell adhesion proteins have been shown to bind multiple postsynaptic protein targets such as leucine-rich repeat transmembrane neuronal proteins (LRRTMs) and neuroligins (depicted in Fig. 1 , reviewed in Südhof 2008), and alternatively spliced forms of these proteins exhibit altered affinity for their postsynaptic ligands (reviewed in Reissner et al. 2013 ). This begs the question of whether these regulated splicing systems are physiologically relevant, and, if so, could the dysfunction of these systems explain an ASD-like electrophysiological phenotype consisting of pathogenically increased or decreased synaptic efficacy in various brain circuits?
This question serves as the primary theme of the paper, in which Aoto and colleagues (2013) created a knock-in transgenic mouse to constitutively express Nrxn3 proteins that include exon 20. Aoto et al. focused on Nrxn3 due to this isoform exhibiting "the largest differential in expression" based on qrtPCR analysis. The exon 20 sequence is regulated at splice site 4; therefore, these animals are referred to as the SS4ϩ genotype. The selection of this particular splice site as a genetic target in this study is based on previous reports showing the SS4 locus to be a potent regulator of Nrxn protein function and binding to multiple ligands including ␣-latrodotoxin, neuroligans, LRRTMs, and cerebelline (Boucard et al. 2012) . By including loxP sites flanking exon 20, cre-recombinase-mediated excision of this exon allowed for constitutive expression of Nrxn3 proteins lacking exon 20-encoded residues, thus forming the SS4Ϫ genotype. Importantly, both genotypes showed no differences in overall Nrxn mRNA levels compared with wild type (WT), giving no reasonable suspicion that there would be differences in Nrxn protein levels between trangenics and WT controls.
Finally, electrophysiological data showed significant reductions in ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor-mediated synaptic transmission in both cultured and acute slice preparations specifically in the SS4ϩ genotype neurons compared with SS4Ϫ and WT genotypes.
Subsequent experiments in cultured preparations went on to further characterize this synaptic deficit, using cDNA constructs to overexpress different Nrxn proteins, as well as pulse-labeling assays to detect changes in AMPA receptor cycling. These experimental results were tested in acute hippocampal slices using the same transgenic genotypes, and similar reductions in AMPA receptor-mediated transmission were found. As for the altered function of the SS4Ϫ Nrxn3 and its contribution to the reductions in AMPA receptor-mediated currents, Aoto et. al (2013) found a significant reduction in postsynaptic LRRTM2 surface expression at SS4Ϫ Nrxn3 synapses. This finding, coupled with the finding that neuroligin1 showed no significant alterations in surface expression, suggests that SS4 alternative splicing controls the stabilization of the synapse via binding affinity to postsynaptic ligands and their associated complexes. While there is no clearly defined This altered structural efficacy (characterized by red arrow, describing suboptimal levels of neurotransmission) is thought to involve the lateral diffusion of AMPA receptor complexes away from the active zone and/or the possible internalization of the AMPA receptor complex. This system is depicted on the left as having an impact on pyramidal cell dendritic inputs and would undoubtedly have similar effects on cultured neuronal networks. B: synapses in the SS4Ϫ genotype contain Nrxn proteins that impart WT levels of synaptic efficacy (characterized by green arrow, describing normal neurotransmission). Exon 20 lacking Nrxn proteins help align postsynaptic AMPA receptors with the presynaptic active zone. AMPA, ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; LRRTM, leucine-rich repeat transmembrane neuronal protein; TARP, transmembrane AMPA receptor regulatory protein.
shift from one postsynaptic ligand to another, based on exon 20 exclusion, these data convey a mechanism by which Nrxn3 splicing can potentially regulate excitatory synaptic efficacy.
An initial, yet minor criticism is based on a very peculiar finding during cDNA rescue experiments seeking to reverse the deficit in AMPAR EPSCs (AMPA receptor-mediated excitatory postsynaptic currents) in the SS4ϩ genotype. Panels C and D in Fig. 2 in Aoto et al. (2013) show reversal of the SS4ϩ deficit in AMPA-mediated, evoked EPSCs using cDNA rescue with Nrxn1␤ SS4Ϫ, as well as Nrxn2␤ SS4Ϫ cDNA, with no effect using the SS4ϩ forms of these genes. As mentioned here earlier, the sole distinction in the genotypes is restricted to the presence of exon 20 in Nrxn3 proteins. This genetic manipulation affects both ␣-and ␤-isoforms of the Nrxn3 proteins, leaving splicing and expression of Nrxn1 and Nrxn2 proteins (both ␣-and ␤-forms) unaffected. An initial interpretation of the cDNA rescue is that some amount of redundancy exists between the Nrxn proteins at the presynaptic membrane (reviewed in Reissner et al. 2013 ). However, without quantification of relative Nrxn1 and Nrxn2 mRNA and protein levels in neurons from both genotypes, these findings remain an unpredicted and unexplored area of the paper. Based on the proposed mechanism by which the SS4Ϫ genotype allows for proper alignment of presynaptic machinery and postsynaptic receptor complexes, we can assume that these alternate cDNA molecules are somehow increasing alignment in the SS4ϩ genotype, although the exact mechanism is unknown.
As touched on in the paper, ASD phenotypes are thought to have much more complex genetic causes than simple Mendelian inheritance patterns. Multiple polygenic models have been derived to account for the variable behavioral phenotypes and levels of penetrance in human ASD as well as transgenic animals' neurophysiological phenotypes (Berg and Geschwind 2012) . A seemingly viable criticism to this paper would be that the transgenic design undertaken in these studies, control of alternate splicing for a single exonic sequence in Nrxn3, does not reflect the more popular polygenic models of ASD genetics. While it is hypothesized that the majority of diagnosed ASD cases are caused by polygenic mutations (Berg and Geschwind 2012) , the current work serves to illuminate very specific forms of these mutations.
Returning to the contemporary theories of ASD circuit dysfunction, the cell adhesion hypothesis is well in line with the notion that gene mutations affecting specific brain circuits are responsible for the altered connectivity underlying ASD behavioral phenotypes. These studies demonstrate the profound effect that a single exonic sequence can have on synaptic function in both cultured neuronal networks and acute hippocampal slices. To further probe these overarching concepts of region-specific synaptic dysfunction, and to provide additional characterization of the novel transgenic lines created for these studies, electrophysiological recordings of alternate brain regions would be highly beneficial. For example, recordings from striatum or amygdala circuits examining possible alterations in AMPAR currents would serve to further characterize the proposed ASD synaptic phenotype of these transgenic mice. This touches on a recurrent theme of the ASD pathogenesis with regard to anatomical differences in the ASD phenotype. Similar to the complex models of genetic causes of ASD, with no single gene to blame for the ASD phenotype, the search for a single structure whose disruption can account to the ASD behavioral phenotype has been largely inconclusive. Current theories on the neuroanatomical components of ASD have shifted focus to brain areas of the highest circuit interconnectivity. The amygdala is an exemplary structure to fit these criteria, with its embedded synaptic connectivity spanning the entire limbic system, and also a wealth of literature showing amygdala abnormalities, both functional and anatomical, in ASD patients (reviewed in Zalla and Sperduti 2013) . Similarly, the striatum exhibits heterogeneity in its synaptic connectivity with its monosynaptic inputs from cortex, and its circuits spanning the thalamus, basal ganglia, and then indirectly back to cortex (reviewed in Shepherd 2013). Given these characteristics, as well as the ample expression of all three types of neurexin proteins in these brain regions, electrophysiological recordings from these brain areas would have been a great addition to this paper, by not only further validating this transgenic animal as a viable model for ASD, but also to strengthen the notion that varying degrees of synaptic dysfunction are directly related to varying levels of Nrxn protein expression. This is by no means a vital piece of data lacking in the paper, but the initial characterization of Nrxn mRNA expression across brain regions (Fig. 1A above) suggests the strong possibility of alternate synaptic phenotypes at different CNS synapses.
In a more broad analysis of the transgenic animals employed in this study, it is important that the genotype meant to model the genetic components of the disease produce a phenotype that also closely follows the physiological dysfunctions seen in human subjects. Thus far, these mice have exhibited synaptic deficit consistent with proposed ASD neurophysiological phenotype. While it is by no means a point of criticism that behavioral analysis is not included in the current publication (there is little doubt that this data, if not already collected, will be included in a future publication), the behavioral validation of these transgenic mice as a viable model for ASD will be a vital component in the future of this research.
Previous work using conventional Nrxn knockout mice has shown a neonatal mortality when all three genes are removed (Missler et al. 2003) . Targeted removal of ␣-Nrxn alone resulted in mice with normal neuroanatomical and synaptic organization; however, electrophysiological studies revealed similar forms of synaptic dysfunction (Zhang et al. 2005) . It is becoming clear that conventional Nrxn knockout strategies can only go so far as to reveal the complex relationship between synaptic cell adhesion molecules and synaptic transmission. This paper, and the subtle genetic manipulations employed, signify a new trajectory in the field that is equipped to piece apart the highly regulated splicing of synaptic adhesion proteins and the underlying pattern of expression which contributes to synaptic efficacy. The final conclusions made by the investigators describe a system of presynaptic NRXN splicing that allows for the "fine tuning" of synaptic efficacy following initial synapse formation. Contrary to a simple reduction in SS4ϩ Nrxn affinity to normal postsynaptic target proteins, investigators proposed a more complex mechanism involving altered dynamics in the binding of Nrxn proteins to multiple postsynaptic proteins. These proposed mechanisms touch on a well-known but often underemphasized concept in neurological disorders: synapses are highly dynamic entities, with each protein and lipid component of the system subject to rapid molecular turnover. Putting alternatively spliced proteins into play can alter the efficacy of the synapse, which is measured electrophysiologically as altered postsynaptic currents. This concept is perfectly showcased in the cDNA rescue experiments in this paper, with a reversal of the SS4ϩ deficit in AMPA EPSC amplitude constituting a shift in the SS4ϩ genotype back to the WT state of synaptic efficacy.
A broad interpretation of these findings would suggest that a human ASD genotype involving NRXN mutations would manifest as an individual with abnormal synaptic efficacy at one or more brain regions. In essence, the neuronal network would display proper anatomical connectivity, but with synapses lacking in the fine tuning allowed under normal splicing dynamics of synaptic cell adhesion proteins, constituting a lack of functional connectivity. Recent MRI studies have shown profound reductions in functional connectivity in autistic subjects (Deshpande et al. 2013) . These studies provide hope that the deficits in synaptic function underlying ASD can one day be reversed; perhaps not with the methodology employed during these experiments, but it is not unwarranted to think that properly targeted therapeutics could restore a normal synaptic equilibrium and relieve the devastating behavioral phenotypes of autism and other spectral disorders.
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